IgAN
1-16 of 16
- IgAN
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
Chee Kay Cheung, MBChB, PhD, FRCP
Jürgen Floege, MD
Claudia Seikrit, MD
Chee Kay Cheung, MBChB, PhD, FRCP
Claudia Seikrit, MD
Jonathan Barratt, MD, PhD
Chee Kay Cheung, MBChB, PhD, FRCP
Raphael Duivenvoorden, MD, PhD
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Jürgen Floege, MD
- CME/CE
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
0.25 creditsJonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Jörg Latus, MD
Jürgen Floege, MD
Jörg Latus, MD
Chee Kay Cheung, MBChB, PhD, FRCP
Jörg Latus, MD
Sydney Tang, MBBS, MD
- CME/CE
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
0.25 creditsJürgen Floege, MD
Jonathan Barratt, MD, PhD
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
Jonathan Barratt, MD
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Jonathan Barratt, MD, PhD
Annette Bruchfeld, MD, PhD
Jonathan Barratt, MD, PhD
Donald E. Kohan, MD, PhD
